See Me and Not Just the Disease! An In-Depth Clinical Focus on Racial Disparities in HCV Care Globally

In this program, Ahmed M. Elsharkawy PhD, FRCP(UK), discusses the most-important barriers to effective hepatitis C virus (HCV) management in diverse ethnic populations, including both the community barriers that exist within populations affected by HCV and broad global healthcare barriers. As barriers are similar regardless of geographic region, Dr Elsharkawy offers practical solutions based on his experiences and on existing data to overcoming these difficulties both within the United States and globally.

The slide thumbnails in this activity link to individual PowerPoint slidesets, each focused on the specific study or topic of interest. These slidesets may be downloaded by clicking any of the thumbnails within the activity.

Clinical Care Options (CCO) plans to measure the educational impact of this activity. A few questions will be asked twice: once before the discussion that informs the best choice and then again after the specific discussion. Your responses will be aggregated for analysis, and your specific responses will not be shared.

Before continuing with this educational activity, please take a moment to answer the following questions.

Global Prevalence of HCV

This slide shows an overall global perspective on the epidemiology of HCV.¹

It is important for healthcare professionals (HCPs) managing HCV to understand global prevalence rates so a clearer understanding of HCV rates for various ethnic populations, especially first-generation immigrants, can be formed.

What is key to recognize is that prevalence may be different in your immigrant population than in your indigenous population.